Prediction Model of Occult Omental Metastasis in Patients With Gastric Cancer

Last updated: May 5, 2024
Sponsor: Northern Jiangsu People's Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Gastric Cancer

Neoplasm Metastasis

Digestive System Neoplasms

Treatment

Without any intervention, we only divided gastric cancer patients into two groups based on postoperative pathology, and analyzed their basic characteristics and risk factors

Clinical Study ID

NCT06405009
NorthernJiangsu003
  • Ages 18-80
  • All Genders

Study Summary

A complete omentectomy is typically recommended during radical total gastrectomy for gastric cancer, though its impact on survival remains unclear. This study aimed to assess the frequency and risk factors of metastases in the greater omentum in gastric cancer patients undergoing gastrectomy. It will involve a single prospective cohort of consecutive patients who underwent total gastrectomy with complete en bloc omentectomy and modified D2 lymphadenectomy. Post-surgery, the omentum will dissect from the gastrectomy specimen beyond the gastroepiploic vessels and examine separately for pathological assessment. The primary outcome will focus on the detection of omental metastases.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. pathological confirmation of gastric cancer
  2. eligibility for surgical intervention
  3. undergoing first rectal cancer surgery
  4. acquisition of written informed consent from patients and their families
  5. no history of hypertrophic scar or allergic predispositions

Exclusion

Exclusion Criteria:

  1. absence of postoperative pathology of the omentum
  2. diagnosis of multiple primary malignancies
  3. intraoperative discovery of widespread implant metastases within the abdominal cavity
  4. severe comorbidities

Study Design

Total Participants: 450
Treatment Group(s): 1
Primary Treatment: Without any intervention, we only divided gastric cancer patients into two groups based on postoperative pathology, and analyzed their basic characteristics and risk factors
Phase:
Study Start date:
April 22, 2024
Estimated Completion Date:
June 30, 2024

Connect with a study center

  • Yifan Cheng

    Yangzhou, Jiangsu 225000
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.